Administration of EGCG, in combination with a low strength pulsed electric field and a low energy ultrasound treatment, results in increased generation of ROS, autophagy and apoptosis activation, suppression of Akt phosphorylation, and the consequent reduced survival of human pancreatic cancer cells [80]. The gene discussed is AKT1; the disease is familial pancreatic carcinoma.